1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Glioblastoma Multiform: new trials by email Literature Review of Glioblastoma Multiform trials Research Report on Glioblastoma Multiform
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma TLX-101-Tx + Lomustine, TLX101-Tx - Neoplastic Disease, Glioblastoma | Phase 3 | Recruiting | Telix Pharmaceuticals (Innovations) Pty Limited | 51 | 2025-11-02 | 2026-11-16 |
Brain Neoplasms (1) · Central Nervous System Neoplasms (1) · Glioblastoma (1) · Neoplasm Recurrence, Local (1) · Neoplasms (1)
Astrocytoma (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Glioma (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1) · Neoplastic Processes (1) · Nervous System Diseases (1) · Nervous System Neoplasms (1) · Neuroectodermal Tumors (1) · Pathologic Processes (1)
Lomustine (1)
Telix Pharmaceuticals (Innovations) Pty Limited (1)
Australia (1) · Austria (1) · Belgium (1) · Netherlands (1)
2025 (1)